Your browser doesn't support javascript.
loading
Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens.
Cabel, Luc; Carton, Matthieu; Cheaib, Bianca; Pierga, Jean-Yves; Dalenc, Florence; Mailliez, Audrey; Levy, Christelle; Jacot, William; Debled, Marc; Leheurteur, Marianne; Desmoulins, Isabelle; Lefeuvre, Claudia; Gonçalves, Anthony; Uwer, Lionel; Ferrero, Jean-Marc; Eymard, Jean-Christophe; Petit, Thierry; Mouret-Reynier, Marie-Ange; Perrocheau, Geneviève; Piot, Irwin; Pérol, David; Simon, Gaëtane; Lerebours, Florence.
Afiliação
  • Cabel L; Institut Curie, 35 rue Dailly, 92210, Saint-Cloud, France. Luc.cabel@curie.fr.
  • Carton M; Institut Curie, 35 rue Dailly, 92210, Saint-Cloud, France.
  • Cheaib B; Gustave Roussy, 94805, Villejuif, France.
  • Pierga JY; Institut Curie, 35 rue Dailly, 92210, Saint-Cloud, France.
  • Dalenc F; Institut Claudius regaud-IUCT-Oncopole, 31059, Toulouse, France.
  • Mailliez A; Centre Oscar Lambret, 59000, Lille, France.
  • Levy C; Centre Francois Baclesse, 14000, Caen, France.
  • Jacot W; ICM, 34298, Montpellier, France.
  • Debled M; Institut Bergonie, 33000, Bordeaux, France.
  • Leheurteur M; Centre Henri Becquere, 76000, Rouen, France.
  • Desmoulins I; Centre Georges-Francois Leclerc, 21000, Dijon, France.
  • Lefeuvre C; Centre Eugene Marquis, 35000, Rennes, France.
  • Gonçalves A; Institut Paoli-Calmettes, 13009, Marseille, France.
  • Uwer L; ICL, 54519, Vandoeuvre-les-Nancy, France.
  • Ferrero JM; Centre Antoine Lacassagne, 06100, Nice, France.
  • Eymard JC; Institut Jean Godinot, 51100, Reims, France.
  • Petit T; Centre Paul Strauss, 67065, Strasbourg, France.
  • Mouret-Reynier MA; Centre Jean Perrin, 63011, Clermont-Ferrand, France.
  • Perrocheau G; ICO, 44805, Nantes, France.
  • Piot I; R&D Unicancer, 75000, Paris, France.
  • Pérol D; Centre Léon Bérard, 69373, Lyon, France.
  • Simon G; R&D Unicancer, 75000, Paris, France.
  • Lerebours F; Institut Curie, 35 rue Dailly, 92210, Saint-Cloud, France.
Breast Cancer Res Treat ; 173(2): 397-406, 2019 Jan.
Article em En | MEDLINE | ID: mdl-30357526
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Etoposídeo / Inibidores da Topoisomerase II Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Etoposídeo / Inibidores da Topoisomerase II Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França País de publicação: Holanda